Hyaluronic Acid

BreastfeedingPediatric
  • TRADE NAMES: Adant; Aquamid; ARTZ; DermaDeep; DermaLive; Euflexxa (Ferring); Hyalgan (Sanofi-Aventis); Hylaform; Hylan G-F 20 (Synvisc); Juvederm (Allergan); Orthovisc; Perlane (Q-Med AB); Restylane Fine Lines (Medicis); Supartz; Vitrase (ISTA Pharma)
  • INDICATIONS: Oral: joint disorders Injection: adjunct in eye surgery, viscosupplementation in orthopedics, cosmetic surgery Topical: wounds, burns, skin ulcers, stomatitis
  • SYNONYM: Hyaluronan
  • CLASS: Dermal filler, Food supplement, Glycoaminoglycan
  • HALF-LIFE: 2.5–5.5 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Furosemide, Local anesthetics, NSAIDs, Oral anticoagulants

PREGNANCY CATEGORY: C

Most reported reactions relate to orthopedic use.

Our database has 72 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 08/22/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top